ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
FDA halts Xencor’s study of XmAb14045 following deaths pharmaceutical-technology
February 22, 2019California-based Xencor has announced the US Food and Drug Administration (FDA) has placed a partial clinical hold on its Phase I trial of its acute myeloid leukaemia drug XmAb14045 following the deaths of two participants....
Pharma Sources Insight January 2025
